Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
2
22%
Ph phase_1
4
44%
Ph early_phase_1
1
11%
Ph phase_3
2
22%

Phase Distribution

5

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
4(44.4%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 14 (44.4%)
Phase 32 (22.2%)
Phase 42 (22.2%)

Trials by Status

completed889%
terminated111%

Recent Activity

0 active trials
Showing 5 of 9
completedearly_phase_1

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

NCT04200911
completedphase_1

Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

NCT04996719
completedphase_1

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

NCT01853423
completedphase_1

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT00286156
terminatedphase_1

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

NCT00337376
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04200911Early Phase 1

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

Completed
NCT04996719Phase 1

Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

Completed
NCT01853423Phase 1

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Completed
NCT00286156Phase 1

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Completed
NCT00337376Phase 1

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Terminated
NCT00248313Phase 3

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Completed
NCT00044720Phase 4

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Completed
NCT00195481Phase 4

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Completed
NCT00470665Phase 3

Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9